Results 71 to 80 of about 2,013,224 (205)

Metachronous Primary Pancreatic Neuroendocrine Tumor and Adenocarcinoma: A Case Report

open access: yesCancer Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, with most patients presenting with advanced disease. Surgical resection remains the only potentially curative option, yet recurrence rates are high. Case We present a rare case of metachronous primary pancreatic neuroendocrine tumor (PanNET) and PDAC in a 71‐year‐old ...
Anastasia S. Fatyanova   +7 more
wiley   +1 more source

Antipsychotic dose escalation as a trigger for Neuroleptic Malignant Syndrome (NMS): literature review and case series report [PDF]

open access: yes, 2012
Background: “Neuroleptic malignant syndrome” (NMS) is a potentially fatal idiosyncratic reaction to any medication which affects the central dopaminergic system. Between 0.5% and 1% of patients exposed to antipsychotics develop the condition.
Daniel J Smith   +11 more
core   +2 more sources

The Malignant Carcinoid Syndrome [PDF]

open access: yesCirculation, 1959
R E, SCHNECKLOTH   +2 more
openaire   +2 more sources

A review of neuroleptic malignant syndrome : incidence and features in Malta [PDF]

open access: yes, 1995
This paper describes Malta’s first sample of Neuroleptic Malignant Syndrome (NMS) and reviews the current literature. A retrospective sample of all diagnosed cases of NMS was reviewed using Pope’s (1986) criteria. Twelve cases were identified yielding an
Grech, Anton, Saliba, Joseph R.
core  

Primary aldosteronism due to adrenocortical adenoma with concurrent ileum carcinoid tumor: case report

open access: yes, 2010
Primary aldosteronism (PA) with synchronous carcinoid syndrome is extremely rare occurrence. In this article, we describe a case of PA due to adrenocortical adenoma ("aldosteronoma") and concurrent malignant carcinoid tumor of ileum.
A. Ciardi   +14 more
core   +1 more source

Developments in the treatment of carcinoid syndrome – impact of telotristat

open access: yes, 2018
David L Chan, Simron Singh Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Abstract: Carcinoid syndrome occurs in 20% of patients with neuroendocrine tumors, and serotonin is usually the main causative hormonal peptide ...
Chan DL, Singh S
core  

Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1

open access: yes, 2001
Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant tumour syndrome. It is characterized by primary hyperparathyroidism, pituitary neoplasia and foregut lineage neuroendocrine neo-plasia.
John Burgess (14732812)   +2 more
core  

Ectopic ACTH-Dependent Cushing’s Syndrome Caused by Bronchial Carcinoid

open access: yes, 2015
The article presents the concept of ectopic ACTH-secreting tumors of the neuroendocrine system. There was described a rare case of ectopic ACTH-dependent Cushing’s syndrome caused by bronchial carcinoid, in the clinical pattern of which, along with ...
N.I. Stankova   +2 more
core   +1 more source

Multifocal small cell neuroendocrine carcinoma of the jejunum, ileum and caecum: A rare case with intestinal obstruction and perforation

open access: yesInternational Journal of Gastrointestinal Intervention
Neuroendocrine tumours of the small intestine are sporadic and may be of large- or small-cell type. The ileum and jejunum are most frequently affected by this malignant neoplasm, which exhibits a high tendency towards multifocality and metastatic spread.
José Richard Tenazoa-Villalobos   +3 more
doaj   +1 more source

Five Advances in the Last 50 Years That Have Impacted Endocrine Surgery

open access: yes
World Journal of Surgery, Volume 50, Issue 8, Page 2071-2076, August 2026.
Matilda Anneback   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy